Figure 3.
Decision-curve analysis of MELDNa-5MGS versus MELD-Na for the prediction of 2-year mortality in cirrhosis.
MELD-Na, model for end-stage liver disease-sodium; MELDNa-5MGS, MELDNa-5-m gait speed.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.